Baxter International Inc. (BAX)
Last Price$34.91.0%
Market Cap$17.9B
BAX Rating
BAX Quality rating performance
BAX Intrinsic Value
Key Highlights:
As of Mar 03, 2025 BAX Relative Value is $63.3, which is undervalued by 81.6%, compared to current share price of $34.9.
As of Mar 03, 2025 BAX DCF Value is $43.1, which is undervalued by 23.5%, compared to current share price of $34.9.
BAX Share Price History
1W (0.6%)
1M 10.2%
6M (7.4%)
YTD (7.7%)
1Y (16.2%)
3Y (56.0%)
5Y (55.3%)
10Y 9.0%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
BAX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$17.9B
$29.6B
$12.9B
$566.0M
Shares Outstanding
514M
Employees
38K
Growth (CAGR)
2.5%
N/A
(16.7%)
148.7%
Profitability
37.1%
(1.1%)
(5.0%)
7.9%
4.4%
(91.9%)
Intrinsic Value
$52.7 (51.1% undervalued)
$42.7
$62.7
(14.4%)
Valuation (LTM)
Return on Capital
Financial Health
$1,764.0M
$11.7B
20.6x
(0.4x)
191.5%
Dividends
9.0%
3.3%
104.2%
Nov 29, 2024
Earnings
Apr 30, 2025
MISS by (42.5%)
BEAT by 2.5%
(1.2%)
6 Beat & 4 Miss
BAX Stock Financials
BAX Income Statement Metrics
Annual
Quarterly
LTM
BAX Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$0.0 -41.0% YoY
Capital Expenditure (CAPEX)
($446.0M) -34.8% YoY
Free Cash Flow (FCF)
($446.0M) -45.3% YoY
BAX Income Statement Overview
Crunching data... Almost there!
BAX Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$25.8B
Current assets ($8,853.0M, 34.3% of total)
$1,764.0M (6.8%)
$1,679.0M (6.5%)
Other current assets
$5,410.0M (21.0%)
Non-current assets ($16.9B, 65.7% of total)
$0.0 (0.0%)
$3,176.0M (12.3%)
$5,223.0M (20.3%)
Other non-current assets
$8,530.0M (33.1%)
Financial position
$11.6B
Cash & Short-term
Investments
Total Debt
BAX Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
BAX Earnings Surprises
Crunching data... Almost there!
BAX Dividends
BAX Dividend Yield
Crunching data... Almost there!
BAX Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with BAX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$17.9B | 4.7 | $52.7 51.1% undervalued | (16.2%) | $12.9B | $566.0M | (14.0%) | 4.4% | 37.1% | (1.5%) | 191.5% | |
$207.3B | 6.9 | $106.1 81.3% overvalued | 41.5% | $8,352.1M | $1,077.2M | 17.2% | 12.9% | 67.5% | 26.8% | 0.0% | |
$66.3B | 6.1 | $262.7 15.0% undervalued | (1.4%) | $20.6B | $2,936.0M | 5.9% | 14.2% | 59.4% | 5.4% | 55.9% | |
$46.6B | 6.4 | $81.3 13.6% overvalued | 9.9% | $9,926.1M | $608.0M | 3.6% | 6.1% | 55.6% | 9.1% | 23.8% | |
$34.6B | 7.6 | $190.6 18.2% overvalued | 29.9% | $4,926.8M | $1,388.4M | 12.9% | 28.2% | 57.9% | 32.9% | 16.0% | |
$18.6B | 5.8 | $92.7 1.2% undervalued | (10.8%) | $3,895.4M | $288.1M | 8.4% | 7.4% | 62.8% | 5.9% | 32.0% | |
$16.9B | 6.1 | $152.8 33.0% overvalued | (36.3%) | $2,893.1M | $276.4M | (1.9%) | 9.6% | 34.6% | 18.6% | 11.3% | |
$14.7B | 7.3 | $131.7 108.2% undervalued | (15.2%) | $4,038.9M | $1,135.5M | 1.8% | 28.1% | 56.2% | 13.2% | 1.0% | |
$10.4B | 5.2 | $139.9 26.6% overvalued | 50.3% | $2,094.4M | $145.3M | 2.3% | 6.9% | 48.0% | (14.8%) | 69.2% | |
$9,757.8M | 6.5 | $174.5 19.0% undervalued | 4.2% | $3,582.9M | $349.2M | 2.7% | 9.7% | 48.7% | 12.0% | 27.7% | |
$8,979.7M | 5.9 | $29.8 80.8% overvalued | (20.6%) | $616.0M | $131.3M | (8.0%) | 21.3% | 46.9% | (1.2%) | 33.3% |
FAQ
What is Baxter International Inc. (BAX) stock rating?
As of today, Baxter International Inc. has a stock rating of 5 (out of 10), which is considered Good.
is Baxter International Inc. (BAX) a good stock to buy?
As of today, Baxter International Inc. has a Good stock rating, which is 51.1% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.